The Nation Newspaper

Zenith Bank Women’s B’ball League: Nigeria Customs, First Bank rule Phase 1

The Phase 1 of the NBBF/Zenith Bank Women’s Basketball League came to an end with two teams maintaining a winning streak in the two centres. Nigeria Customs and First Bank of Lagos are the two teams ...
The Nation Newspaper

NBBF/Zenith Bank Women Basketball: First Bank, Customs unbeaten as Phase One ends

It was perfect results for record title holder of the NBBF/Zenith Bank Women Basketball team, First Bank Women’s Basketball team, as they showed class during the Phase One of the current league season ...
Nasdaq

Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis

Second positive phase 3 trial adds to growing body of evidence for WINREVAIR, an activin signaling inhibitor therapy that targets an underlying cause of PAH RAHWAY, N.J.--(BUSINESS WIRE)-- Merck (NYSE ...
News Medical

WINREVAIR™ (sotatercept-csrk) reduced the risk of a composite of all-cause death, lung transplantation and hospitalization for pulmonary arterial hypertension (PAH) by 76% ...

Merck, known as MSD outside of the United States and Canada, today announced the first presentation of results from the Phase 3 ZENITH trial evaluating WINREVAIR ™ (sotatercept-csrk) compared to ...
MarketWatch

Alnylam Announces First Patient Dosed in ZENITH Global Phase 3 Cardiovascular Outcomes Trial of Zilebesiran

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the first patient has been dosed in ZENITH (ZilebEsiraN CardIovascular OuTcome Study in ...
Seeking Alpha

Merck Announces Pivotal Phase 3 ZENITH Trial Evaluating WINREVAIR™ (sotatercept-csrk) Met Primary Endpoint at Interim Analysis

WINREVAIR met primary endpoint of time to first morbidity or mortality event for the treatment of patients with pulmonary arterial hypertension (PAH) functional class III or IV at high risk of ...